Kiesel, B; Syboeck, K; Schnitzenlehner, L; Spiro, Z; Widhalm, G; Mair, MJ; El-Heliebi, A; Freyschlag, CF; Gruber, A; Leibetseder, A; Mahdy-Ali, K; Marhold, F; Nowosielski, M; Oberndorfer, S; Pichler, J; Pieber, TR; Prietl, B; Spiegl-Kreinecker, S; Stanzer, S; Purkart, TU; Woehrer, A; Preusser, M; Berghoff, A.
FACTORS IMPACTING THE QUALITY OF PATIENT-DERIVED CELLS (PDCS) FOR DRUG SCREENING IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
NEURO-ONCOLOGY. 2025; 27: iii30-iii31.
Doi: 10.1093/neuonc/noaf193.090
Web of Science
FullText
FullText_MUG